What Has Been the Growth Trajectory of the Coronary Artery Disease Market?
The coronary artery disease market has seen considerable growth due to a variety of factors.
•The size of the coronary artery disease market has seen significant expansion lately. Predictions suggest that it will escalate from $29.15 billion in 2024 to $31.97 billion in 2025, possessing a compound annual growth rate (CAGR) of 9.7%.
Factors such as the rising prevalence of coronary artery disease, the surge in minimally invasive surgical procedures, the increase in inactive lifestyles, the ageing population, and the evolution of pharmacological treatments have all contributed to its growth during the historical period.
What Does the Future Hold for the Coronary Artery Disease Market?
The coronary artery disease market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the coronary artery disease market to experience swift expansion in the coming years. The market is projected to reach $48.48 billion by 2029, with a compound annual growth rate (CAGR) of 11.0%.
This anticipated expansion during the forecast timeframe can be credited to factors like lifestyle changes, an emphasis on telemedicine and remote health monitoring, an increase in interventional cardiology procedures, a shift towards value-oriented healthcare paradigms, and the introduction of innovative drug treatments. Significant trends for the predicted period involve the exploration of gene therapies, the incorporation of artificial intelligence in clinical diagnosis, special attention to mental health in CAD treatment, an escalation in home-based health services, and the practice of remote cardiac recovery.
What Main Forces Are Fueling Expansion In The Coronary Artery Disease Market?
An anticipated escalation in coronary artery disease instances is set to fuel the expansion of the coronary artery disease market in the upcoming years. Coronary artery disease (CAD), a medical ailment typified by the constriction or obstruction of the coronary arteries that provide blood supply to the heart muscle, is seeing rising incidences as a result of factors such as diet alterations, stress, sedentary lifestyles, obesity, age, among others. Treatment for coronary artery disease involves medication such as clopidogrel, ticagrelor, warfarin, and heparin, as well as procedures like coronary artery bypass grafting, angioplasty, and stenting. For example, the Centre of Disease Control and Prevention revealed in May 2024 that coronary heart disease (CHD) was the principal type of heart disease, leading to 371,506 deaths in 2022. About 5% of adults aged 20 and above (1 in 20) suffered from coronary artery disease (CAD), and approximately 1 out of 5 cardiovascular disease (CVD) deaths in 2022 involved adults below 65 years. Thus, the anticipated increase in coronary artery disease instances is expected to stimulate growth in the coronary artery disease market throughout the forecasted period.
What Are The Primary Segments In The Global Coronary Artery Disease Market?
The coronary artery disease market covered in this report is segmented –
1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors, Other Medications
2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery, Other Surgical Interventions
3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies
4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices
Pre-Book The Coronary Artery Disease Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Coronary Artery Disease Market?
In an attempt to be competitive in the coronary artery disease market, leading companies are focusing on the creation of innovative technologies such as artificial intelligence (AI)-powered blood tests. This type of test utilizes AI algorithms for the analysis and interpretation of blood-data. For example, US-based AI-integrated genetic-epigenetic engine manufacturer, Cardio Diagnostics Holdings, unveiled PrecisionCHD in February 2023. This is a genetic and epigenetic blood test designed to pinpoint coronary heart disease early. The PrecisionCHD can detect coronary heart disease with over 75% sensitivity in both genders. It's based on machine-learning models drawn from trillions of genomic and epigenomic data points and incorporates both epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.
Who Are the Key Players in the Coronary Artery Disease Market?
Major companies operating in the coronary artery disease market include:
• Pfizer Inc.
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• Amgen Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Aurobindo Pharma Ltd.
• Hikma Pharmaceuticals plc
• Amneal Pharmaceuticals Inc.
• Chiesi Farmaceutici S.p.A.
• Lupin Pharmaceuticals Inc.
• Wockhardt Ltd.
• Honya Medical Inc.
• Idorsia Pharmaceuticals Ltd.
• Cytokinetics Inc.
• Kowa Pharmaceuticals America Inc.
• Sinotau Pharmaceutical Group
• HRV Global Life Sciences
• Barr Pharmaceuticals Inc.
• AdvanceCor GmbH
• Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.
What Is The Most Dominant Region In The Coronary Artery Disease Market?
North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
